Manuel Diaz Gallego

Manuel Diaz Gallego currently serves as an M&A Manager at Insud Pharma, focusing on M&A and investment activities for both Insud Pharma and its shareholders since May 2023. Prior to this role, Manuel worked at EY from December 2018 to May 2023 as an Associate in Strategy and Transactions, specializing in corporate and business valuations for various purposes, including acquisitions and goodwill impairment testing. Before their tenure at EY, Manuel was a Financial Planning Analyst in the Market Access Department at AbbVie from October 2017 to December 2018 and gained early experience as a Research Trainee at Bridgewater Consulting in 2014. Educationally, Manuel holds a Master of Science in Finance from CUNEF and bachelor's degrees in Economics from Universidad de Cantabria and Vrije Universiteit Brussel.